CN107715168A - A kind of functions of stanching and promoting healing uterine neck wound repair anhydrous gel of the microballoon containing bio-vitric - Google Patents
A kind of functions of stanching and promoting healing uterine neck wound repair anhydrous gel of the microballoon containing bio-vitric Download PDFInfo
- Publication number
- CN107715168A CN107715168A CN201710968188.2A CN201710968188A CN107715168A CN 107715168 A CN107715168 A CN 107715168A CN 201710968188 A CN201710968188 A CN 201710968188A CN 107715168 A CN107715168 A CN 107715168A
- Authority
- CN
- China
- Prior art keywords
- parts
- chitosan
- carbomer
- vitric
- stanching
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0031—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
A kind of functions of stanching and promoting healing uterine neck wound repair anhydrous gel of microballoon containing bio-vitric, it is related to the improvement that a kind of Medical wounded surface repairs gel, and in particular to a kind of functions of stanching and promoting healing uterine neck wound repair anhydrous gel of microballoon containing bio-vitric.It is that micropore biological activity glass and chitosan are prepared for main functional component using poloxamer or carbomer as gel matrix material, and the parts by weight of its composition of raw materials are as follows:Carbomer:1~2 part, micropore biological activity glass:3~20 parts, medical glycerine:35.5 65.5 parts, propane diols:25.5 55.5 parts, chitosan:0.8~2.0 part, Sodium Hyaluronate:0.2~1.0 part.The present invention reduces bleeding, long-acting bacteriostatic, wound healing by the suction-operated of micropore biological glass and the hemostasis of bioactivity glass and chitosan, promotion healing function.It is a functional medical device product having a extensive future.
Description
Technical field
The present invention relates to the improvement that a kind of Medical wounded surface repairs gel, more particularly to a kind of hemostasis of microballoon containing bio-vitric
Promoting healing uterine neck wound repair anhydrous gel.
Background technology
Micropore glass is a kind of particulate porous glass, good, the high mechanical strength of rigidity, mainly for the production of vagcor,
Applied to bioengineering, genetic engineering, the refined and solidification enzyme of biology and medicines.
Micropore glass has developed into many purposes due to its distinctive composition, structure and possessed characteristic
New function material.Medically, the medical seperation films such as blood purification can be used as.
Hydrogel is the gel using water as decentralized medium.One is introduced in water soluble polymer with cross-linked network
Divide hydrophobic grouping and hydrophilic residue, hydrophilic residue and water molecules, hydrone is connected to netted inside, and hydrophobic residue is met
Water swellable cross-linked polymer.It is a kind of macromolecule network system, property is soft, can keep certain shape, can absorb a large amount of
Water.
The mode and means that medical wound at present, surface of a wound hemostasis are repaired are varied, including all kinds of physical methods, chemistry
These methods such as method, hydrogel respectively have advantage and disadvantage, and some haemostatic effects are poor, aqueous in some dispensings, and aqueous gel can be led
Wound, the surface of a wound is caused to be not easy to heal.
Chinese patent 201610665254.4 disclose a kind of wound healing and repair cervical mucosa gel, it by
Carbomer, triclosan, hyaluronic acid, basic fibroblast growth factor, transforming growth factor β, sodium hydroxide, pure water group
Into, carbomer 1%-3%, triclosan 0.1%-0.5%, hyaluronic acid 0.05%-0.1%, basic fibroblast growth because
Sub- 0.000001%-0.00005%, transforming growth factor β 0.000001%-0.00005%, sodium hydroxide 0.05%-
0.1%th, pure water surplus.
The content of the invention
In view of the defects and deficiencies of the prior art, the present invention intends to provide a kind of hemostasis of microballoon containing bio-vitric
Promoting healing uterine neck wound repair anhydrous gel, it passes through the suction-operated of micropore biological glass and bioactivity glass and chitosan
Hemostasis, promote healing function, reduce bleeding, long-acting bacteriostatic, wound healing;With haemostatic effect is good, neutralization is oozed out, is resisted
The advantages that inflammation, induction epithelium regeneration, wound healing is can speed up, reduces recurrence.
To achieve the above object, the present invention is using following technical scheme:It using poloxamer or carbomer is solidifying that it, which is,
Matrix material, micropore biological activity glass and chitosan are prepared for main functional component, the parts by weight of its composition of raw materials
Number is as follows:Carbomer:1~2 part, micropore biological activity glass:3~20 parts, medical glycerine:35.5-65.5 parts, propane diols:
25.5-55.5 parts, chitosan:0.8~2.0 part, Sodium Hyaluronate:0.2~1.0 part.
The present invention is healed by the suction-operated of micropore biological glass and the hemostasis of bioactivity glass and chitosan, promotion
Function, reduce bleeding, long-acting bacteriostatic, wound healing.It is a functional medical device product having a extensive future.It
Main feature:
1st, anastalsis:By nanometer level microporous and chitosan powder, can quick adsorption blood reduce bleeding rapidly;
2nd, neutralize and ooze out, anti-inflammatory:The specific PH of bio-vitric, sepage and anti-inflammatory are effectively neutralized, preferable healing environment is created, subtracts
Few scabies secondary infection;
3rd, epithelium regeneration is induced:Bioactivity glass promotes synthesis and part of the 4th type collagen fiber albumen and epidermal growth factor
Secrete, actively induce the propagation of epithelial cell, break up and divide a word with a hyphen at the end of a line, so as to effectively facilitate wound healing;
4th, surface of a wound scar is reduced:Adjust tissue cell proliferation, significantly shorten the wound repair time, so as to reduce the generation of scar;
5th, not water content in being formulated, series reaction, wound healing can gradually occur after gel and interstitial fluid contacts.
After adopting the above technical scheme, the present invention has the beneficial effect that:Quick-acting haemostatic powder reduction is oozed out, the uterine neck of antibacterial anti-inflammatory is repaiied
Multiple gel can speed up wound healing, reduce wound recurrence.
Embodiment
Embodiment 1
The present embodiment use technical scheme be:It is the micropore biological using poloxamer or carbomer as gel matrix material
Activity glass and chitosan are prepared for main functional component, and the parts by weight of its composition of raw materials are as follows:Carbomer:1 part, it is micro-
Hole bioactive glass:3 parts, medical glycerine:35.5 parts, propane diols:25.5 parts, chitosan:0.8 part, Sodium Hyaluronate:0.2
Part.
Described carbomer selects Acritamer 940.
The present invention is healed by the suction-operated of micropore biological glass and the hemostasis of bioactivity glass and chitosan, promotion
Function, reduce bleeding, long-acting bacteriostatic, wound healing.It is a functional medical device product having a extensive future.It
Main feature:
1st, anastalsis:By nanometer level microporous and chitosan powder, can quick adsorption blood reduce bleeding rapidly;2nd, neutralize and ooze
Go out, anti-inflammatory:The specific PH of bio-vitric, sepage and anti-inflammatory are effectively neutralized, create preferable healing environment, reduce scabies secondary infection;
3rd, epithelium regeneration is induced:Bioactivity glass promotes the synthesis of the 4th type collagen fiber albumen and epidermal growth factor to be secreted with part, main
The propagation of dynamic induction epithelial cell, break up and divide a word with a hyphen at the end of a line, so as to effectively facilitate wound healing;4th, surface of a wound scar is reduced:Adjust tissue
Cell propagation, significantly shorten the wound repair time, so as to reduce the generation of scar;5th, not water content in being formulated, when gel and group
Series reaction, wound healing can gradually occur after knitting liquid contact.
After adopting the above technical scheme, the present invention has the beneficial effect that:Quick-acting haemostatic powder reduction is oozed out, the uterine neck of antibacterial anti-inflammatory is repaiied
Multiple gel can speed up wound healing, reduce wound recurrence.
Embodiment 2
The present embodiment use technical scheme be:It is the micropore biological using poloxamer or carbomer as gel matrix material
Activity glass and chitosan are prepared for main functional component, and the parts by weight of its composition of raw materials are as follows:Carbomer:1.5 parts,
Micropore biological activity glass:10 parts, medical glycerine:45 parts, propane diols:40 parts, chitosan:1.5 parts, Sodium Hyaluronate:0.6
Part.
Embodiment 3
The present embodiment use technical scheme be:It is the micropore biological using poloxamer or carbomer as gel matrix material
Activity glass and chitosan are prepared for main functional component, and the parts by weight of its composition of raw materials are as follows:Carbomer:2 parts, it is micro-
Hole bioactive glass:20 parts, medical glycerine:65.5 parts, propane diols:55.5 parts, chitosan:2.0 parts, Sodium Hyaluronate:1.0
Part.
It is described above, it is merely illustrative of the technical solution of the present invention and unrestricted, those of ordinary skill in the art are to this hair
The other modifications or equivalent substitution that bright technical scheme is made, without departing from the spirit and scope of technical solution of the present invention,
It all should cover among scope of the presently claimed invention.
Claims (5)
- A kind of 1. functions of stanching and promoting healing uterine neck wound repair anhydrous gel of microballoon containing bio-vitric, it is characterised in that:It is to moor Luo Shamu or carbomer are gel matrix material, micropore biological activity glass and chitosan be main functional component prepare and Into the parts by weight of its composition of raw materials are as follows:Carbomer:1~2 part, micropore biological activity glass:3~20 parts, medical glycerine: 35.5-65.5 parts, propane diols:25.5-55.5 parts, chitosan:0.8~2.0 part, Sodium Hyaluronate:0.2~1.0 part.
- 2. a kind of functions of stanching and promoting healing uterine neck wound repair anhydrous gel of microballoon containing bio-vitric according to claim 1, It is characterized in that:It is using poloxamer or carbomer as gel matrix material, and micropore biological activity glass and chitosan are Main functional component is prepared, and the parts by weight of its composition of raw materials are as follows:Carbomer:1 part, micropore biological activity glass:3 Part, medical glycerine:35.5 parts, propane diols:25.5 parts, chitosan:0.8 part, Sodium Hyaluronate:0.2 part.
- 3. a kind of functions of stanching and promoting healing uterine neck wound repair anhydrous gel of microballoon containing bio-vitric according to claim 1, It is characterized in that:It is using poloxamer or carbomer as gel matrix material, and micropore biological activity glass and chitosan are Main functional component is prepared, and the parts by weight of its composition of raw materials are as follows:Carbomer:1.5 parts, micropore biological activity glass: 10 parts, medical glycerine:45 parts, propane diols:40 parts, chitosan:1.5 parts, Sodium Hyaluronate:0.6 part.
- 4. a kind of functions of stanching and promoting healing uterine neck wound repair anhydrous gel of microballoon containing bio-vitric according to claim 1, It is characterized in that:It is using poloxamer or carbomer as gel matrix material, and micropore biological activity glass and chitosan are Main functional component is prepared, and the parts by weight of its composition of raw materials are as follows:Carbomer:2 parts, micropore biological activity glass:20 Part, medical glycerine:65.5 parts, propane diols:55.5 parts, chitosan:2.0 parts, Sodium Hyaluronate:1.0 part.
- 5. a kind of functions of stanching and promoting healing uterine neck wound repair anhydrous gel of microballoon containing bio-vitric according to claim 1, It is characterized in that:Described carbomer selects Acritamer 940.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710968188.2A CN107715168A (en) | 2017-10-18 | 2017-10-18 | A kind of functions of stanching and promoting healing uterine neck wound repair anhydrous gel of the microballoon containing bio-vitric |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710968188.2A CN107715168A (en) | 2017-10-18 | 2017-10-18 | A kind of functions of stanching and promoting healing uterine neck wound repair anhydrous gel of the microballoon containing bio-vitric |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107715168A true CN107715168A (en) | 2018-02-23 |
Family
ID=61211345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710968188.2A Pending CN107715168A (en) | 2017-10-18 | 2017-10-18 | A kind of functions of stanching and promoting healing uterine neck wound repair anhydrous gel of the microballoon containing bio-vitric |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107715168A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108686252A (en) * | 2018-06-11 | 2018-10-23 | 南方医科大学 | It is a kind of using chitosan-poloxamer as nano silver antibiotic dressing of matrix and its preparation method and application |
CN110038156A (en) * | 2019-04-19 | 2019-07-23 | 南通蓝智新材料科技有限公司 | Hemostasis promotees wound healing lotion and preparation method thereof |
CN113546212A (en) * | 2021-08-23 | 2021-10-26 | 克尔维特(福州)医疗科技有限公司 | Liquid dressing with cervical post-operation hemostasis function and infection prevention function and application |
CN114272205A (en) * | 2021-12-30 | 2022-04-05 | 广州朗圣药业有限公司 | Gel with cervical surface protection function |
CN114377193A (en) * | 2022-02-23 | 2022-04-22 | 张慧姊 | Positioning noninvasive repair formula for injection |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101011598A (en) * | 2006-12-15 | 2007-08-08 | 杨春蓉 | Hemostatic, bone impairment renovation material with bioactivity |
CN103830769A (en) * | 2014-03-24 | 2014-06-04 | 贵州扬生医用器材有限公司 | Gynecologic gel with antibacterial restoration activity and preparation method thereof |
CN105169458A (en) * | 2015-09-25 | 2015-12-23 | 胡方 | Biological activity mineral substance material and application of biological activity mineral substance material to soft tissue anabrosis and long-time erosion wound cell regeneration and melanoma restraining |
CN107007874A (en) * | 2017-03-20 | 2017-08-04 | 江西虹景天药业有限公司 | A kind of silicon substrate wound repair aqueous gel and preparation method thereof |
-
2017
- 2017-10-18 CN CN201710968188.2A patent/CN107715168A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101011598A (en) * | 2006-12-15 | 2007-08-08 | 杨春蓉 | Hemostatic, bone impairment renovation material with bioactivity |
CN103830769A (en) * | 2014-03-24 | 2014-06-04 | 贵州扬生医用器材有限公司 | Gynecologic gel with antibacterial restoration activity and preparation method thereof |
CN105169458A (en) * | 2015-09-25 | 2015-12-23 | 胡方 | Biological activity mineral substance material and application of biological activity mineral substance material to soft tissue anabrosis and long-time erosion wound cell regeneration and melanoma restraining |
CN107007874A (en) * | 2017-03-20 | 2017-08-04 | 江西虹景天药业有限公司 | A kind of silicon substrate wound repair aqueous gel and preparation method thereof |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108686252A (en) * | 2018-06-11 | 2018-10-23 | 南方医科大学 | It is a kind of using chitosan-poloxamer as nano silver antibiotic dressing of matrix and its preparation method and application |
CN108686252B (en) * | 2018-06-11 | 2021-05-18 | 深圳英凡妮生物科技有限公司 | Nano-silver antibacterial dressing with chitosan-poloxamer as matrix and preparation method and application thereof |
CN110038156A (en) * | 2019-04-19 | 2019-07-23 | 南通蓝智新材料科技有限公司 | Hemostasis promotees wound healing lotion and preparation method thereof |
CN113546212A (en) * | 2021-08-23 | 2021-10-26 | 克尔维特(福州)医疗科技有限公司 | Liquid dressing with cervical post-operation hemostasis function and infection prevention function and application |
CN114272205A (en) * | 2021-12-30 | 2022-04-05 | 广州朗圣药业有限公司 | Gel with cervical surface protection function |
CN114272205B (en) * | 2021-12-30 | 2023-09-08 | 广州朗圣药业有限公司 | Gel with cervical surface protection effect |
CN114377193A (en) * | 2022-02-23 | 2022-04-22 | 张慧姊 | Positioning noninvasive repair formula for injection |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107715168A (en) | A kind of functions of stanching and promoting healing uterine neck wound repair anhydrous gel of the microballoon containing bio-vitric | |
Graça et al. | Hyaluronic acid—Based wound dressings: A review | |
Arif et al. | Polymer-based biomaterials for chronic wound management: Promises and challenges | |
Beata Łabowska et al. | Methods of extraction, physicochemical properties of alginates and their applications in biomedical field–a review | |
Lee et al. | Enhancement of bio-stability and mechanical properties of hyaluronic acid hydrogels by tannic acid treatment | |
AU2019265757B2 (en) | Wound dressing for treatment of damaged skin | |
Weng et al. | New injectable chitosan-hyaluronic acid based hydrogels for hemostasis and wound healing | |
EP1901786B1 (en) | Biomaterials in the form of fibres for use as medical devices in the treatment of wounds, and their production process | |
Jing et al. | Marine polysaccharides: Green and recyclable resources as wound dressings | |
RU2012107283A (en) | POLYMER COMPOSITIONS OF MODIFIED HYALURONIC ACID AND WAYS OF THEIR APPLICATION | |
CN103394119A (en) | Method for preparing nanometer bionic slow release biomedical dressing by electrostatic spinning | |
CN106110383A (en) | A kind of chitosan alginate dressing and freeze-drying process thereof | |
KR102473363B1 (en) | Spray type hydrogel wound coating preparation method and Spray type hydrogel wound coating thereof | |
CN104586753A (en) | Carboxymethyl chitosan antibacterial film spray and preparation method thereof | |
Zhang et al. | Polysaccharide-based hydrogel promotes skin wound repair and research progress on its repair mechanism | |
Zhang et al. | An extracellular matrix-inspired self-healing composite hydrogel for enhanced platelet-rich plasma-mediated chronic diabetic wound treatment | |
Rozan et al. | The complex hydrogel based on diatom biosilica and hydroxybutyl chitosan for wound healing | |
CN111073001A (en) | Amphoteric glucan hydrogel and application thereof | |
CN112940300A (en) | Preparation method of crosslinked hyaluronic acid gel | |
Ribeiro et al. | Cellulose-based hydrogels in topical drug delivery: A challenge in medical devices | |
KR102580370B1 (en) | Adhesion barrier containing natural-polymer with biocompatibility and DNA fragment mixture, and process for producing the same | |
Xu et al. | Hierarchically cross-linked Gelatin/Tannic acid/Laponite hybrid antimicrobial hydrogel for hemostatic dressings | |
TW201338816A (en) | Fiber-forming hydrogel composition and preparation method | |
CN112169015A (en) | Sodium alginate hydrogel for promoting wound healing and reducing scars and preparation method thereof | |
CN103394118A (en) | Method for preparing slow-release type dressing with micro-nano bionic structure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180223 |